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A im: To identify likely association between blood 
hypertension and hearing loss. Design: A non-paired case-
control study. Setting: Institutional work carried out at 
Universidade Norte do Paraná, in South Brazil. Material and 
Method: 154 cases and 154 controls, both genders, aged 
45 to 64, included in the research after sample estimation. 
Methodology: Hypertension was verified through blood 
pressure readings and by a systematized questionnaire about 
hypertension and the use of medication for blood pressure. 
Hearing was assessed through tonal threshold audiometrics 
and audiologic anamneses. Non-conditional logistic 
regression was used in order to control likely confusion 
or modification of effect of other variables on interest 
associations. Results: There is a significant association 
between blood hypertension and hearing loss. Hearing loss 
in the population under study suggests that hypertension 
is an accelerating factor of degeneration of the hearing 
apparatus due to aging. Conclusions: The results in this 
research, through evidence of association between blood 
hypertension and hearing loss, can allow for an integrated 
work of cardiologists, nephrologists, otorhinolaryngologists, 
audiologists and other health professionals concerned with 
alterations caused by blood hypertension.
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INTRODUCTION
Most adult acquired hearing loss have gradual onset 
and may impair oral language reception.
According to data from the ASHA (American Speech 
- Language - Hearing Association)1, there are currently 28 
million individuals in the USA with some type of hearing 
loss, and 80% of those are irreversible cases. These data 
also show that 4.6% of the individuals between 18 and 
44 years have hearing loss, while 14% of middle aged 
individuals – between 45 and 64 years, and 54% of the 
population above 65 years have some hearing loss. This 
is due to a number of factors, such as intense and/or 
continuous noise exposure, inhalation of toxic substances, 
ingestion of ototoxic drugs, metabolic and circulatory al-
terations, infections, different types of injuries and genetic 
inheritance.
The relevance of Arterial Hypertension as a human 
disease is due to its clinical complications, morbidity and 
mortality, as well as the heavy burden to the patient, fam-
ily and public coffers. Few diseases are responsible for so 
frequent and severe complications as the ones accruing 
from Arterial Hypertension: stroke, heart, kidney and pe-
ripheral vascular insufficiencies. Moreover, it is estimated 
that about half of the deaths of patients above 50 years 
are due to cardiovascular diseases, and 80% of them have 
high blood pressure2.
The size of this “High Blood Pressure” situation in 
Brazil is estimated through rates established on interna-
tional papers, and based on projections from the Brazilian 
Institute of Geography and Statistics Census of 1990, there 
are today about 90 million Brazilians aged above 20 years. 
If we consider the hypertension prevalence to be 20%, 
there must be at least 18 million hypertensive Brazilians, of 
which about 50% are not aware they have the disease2.
Katz3 says that all living cells in the human body 
depend on a proper supply of oxygen and nutrients in 
order to maintain their function, and such supply depend 
on the functional and structural integrity of the heart and 
blood vessels. Hypertension, the most common vascular 
disorder, may facilitate structural changes in the heart 
and blood vessels4. High pressure in the vascular system 
may cause inner ear hemorrhage, which is supplied by 
the anterior inferior cerebelar artery, which supports the 
inner ear artery and is divided into cochlear artery and 
anterior vestibular artery5, which may cause progressive or 
sudden hearing loss3,4. This circulatory system pathology 
may directly affect hearing in a number of ways. One of 
the vascular physiopathological mechanisms described 
is the increase in blood viscosity, which reduce capillary 
blood flow and ends up reducing  oxygen transport, caus-
ing tissue hypoxia, thus causing hearing complaints and 
hearing loss in patients6. Moreover, arterial hypertension 
may cause ionic changes in cell potentials, thus causing 
hearing loss7.
Since the second half of last century, studies have 
analyzed if individuals with arterial hypertension have 
more hearing loss when compared to other individuals. 
However, results have been unclear, and there is the need 
of further studies in this area to prove if there really is a 
prevalence increase of such alteration as far as peripheral 
and central hearing are concerned in the affected popu-
lation.
Initially, Rosen et al.8 stated that in a study carried 
out with hypertensive patients in the USA, there was a 
correlation between high blood pressure and hearing loss 
in high frequencies. However, such correlation was not 
seen by the same authors in a later study carried out with a 
Sudanese native population. Hansen et al.9, in a retrospec-
tive study carried out in Denmark with the charts of 342 
patients assessed between 1945 and 1961, consecutively, 
do not relate arterial hypertension to hearing loss in this 
population.
Marková10, in the Tcheck Republic, after analyzing 
the hearing symptoms of 50 hypertensive patients submit-
ted that arterial hypertension is an important risk factor 
for hearing loss.
Nazar et al.11 , in a study carried out with controlled 
chronic hypertensive patients in specialized centers, with-
out diabetes and without exposure to intense noise and 
ototoxic drugs for at least 3 years, observed that of the 217 
controleld chronic hypertensive patients, most presented 
with hearing alterations; however, with varied audiogram 
profiles. After such study, the authors stated that individual 
predisposing factors (structural or metabolic) may, in iso-
late cases, cause hearing loss, which does not represent a 
habitual development in chronic hypertensive patients.
Brohem et al.12 assessed audiometrically 50 hyper-
tensive patients with ages above 45 years in Brazil, and 
62% of those had sensorineural hearing loss.
In a controlled-case study carried out in Kenya with 
50 elderly individuals using ABR, Chen et al.13 observed a 
relationship between hearing loss and arterial hyperten-
sion in this population. 
Marchiori et al.14, aiming at observing the frequency 
range and the audiometric profile of hypertensive individu-
als, studied 552 audiologic exams from patients referred 
to audiologic assessment. Of the 552 exams studied, 137 
were from patients with arterial hypertension of both 
genders, with ages varying between 14 and 84 years, and 
121 (88.32%) of these hypertensive patients had hearing 
loss, most of them (43.06%) were moderate, sensorineural 
(38.32%), and/or had hearing complaints such as tinnitus, 
fullness in the ear and vertigo. 
Rey et al.15, tested 59 patients with mean age of 
75 years and noticed a significantly negative relationship 
with hypertension. 
Amstutz-Montadert et al.16, reported that in cases 
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of early presbyacusia, around 55 years of age and of 
fast evolution, metabolic or vascular disorders, use of 
ototoxic drugs, nicotine and exposure to noise must be 
investigated, since they all contribute to worsen cases of 
presbyacusia. 
Since there are not too many papers in the literature 
that may lead us to strong evidence, our paper aims at 
checking if there are associations between arterial hyper-
tension and hearing loss in individuals with ages ranging 
between 45 and 64 years.
The results attained with the present research proj-
ect will certainly serve as basis for a greater integration 
between cardiologists, nephrologists, otorhinolaryngolo-
gists, speech therapists and other health care professionals 
involved with arterial hypertension and hearing loss care, 
bringing about relevant data for the professionals involved 
in order to improve quality of care in the therapy and 
rehabilitation of these patients.
METHODS
This research was carried out through a case-
controlled study, after the project was analyzed and ap-
proved, and an informed consent was signed, pertaining 
to resolution 196/96-CNS, for the duration of the project, 
that extended to 2004.
308 middle aged individuals were part of the re-
search (aged between 45 and 64 years). The 154 patients 
with hearing loss (incident cases) were obtained in the 
sequence of medical visits, while the 154 individuals with-
out hearing loss (controls) were recruited by the patients 
themselves, under the instruction that they had to live close 
to the patients they were matching and could not be sib-
lings or parents, in order to avoid genetic biases regarding 
both Arterial Hypertension and Hearing loss.
We excluded patients with previous history of: spe-
cific hearing disorders (such as rubella and head injuries), 
specific metabolic disorders (such as diabetes) and specific 
vascular disorders (such as strokes), and also individuals 
who worked or had worked in an environment that could 
cause noise-induced hearing loss, patients with kidney 
diseases and with prior history of hospital stay or inges-
tion of potentially ototoxic medication or drugs were also 
taken off the study.
The major variable of exposure in our study was 
Arterial Hypertension, and the outcome variable was 
hearing loss.
The instrument for hearing assessment was an audi-
ologic interview which is routinely used in the department 
of Audiology - UNOPAR, based on the interview protocol 
(Katz3) and the tonal threshold audiometry considered a 
gold standard for the evaluation of the auditory threshold 
in adults17 , written in the tonal audiometry form used in 
the routine audiologic visit at UNOPAR and passed in the 
Winaudio database in order to be stored and printed for 
the patient.
In order to assess blood pressure we used a tool for 
systematized clinical data filling out and some questions:
Identification data: name, age, gender, schooling.
Weight, height, arterial pressure.
Questions:
1. Do you have high blood pressure? 
( ) yes ( ) no
2. Have you had your blood pressure measured 
recently? 
( ) yes( ) no
3. When was the last time you measured your blood 
pressure?
4. What has been your blood pressure recently? 
SP X DP
5. Which physician or Health Care facility controls 
your blood pressure?
6. Do you usually take medication to control your 
blood pressure? 
( ) yes ( ) no
7. Which medication (s) do you take?
Blood pressure was measured indirectly with a 
proper cuff and mercury gauge - Tycos®. We respected 
the guidelines established by the III Brazilian Consen-
sus on Hypertension of 1998, which are equivalent to 
the standards proposed by the European Society of 
Hypertension18,19.
Patients with arterial blood pressure ≥ 140 x 90mm 
of Hg in different measures, and those who answered 
yes to questions 1 and 6 and identified the medication(s) 
they were using were considered positive for high blood 
pressure.
We noticed this association between hearing loss 
and each one of the variables in a first stage (raw analysis), 
through the attainment of an odds ratio estimate per point 
and per range, besides the Mantel-Haenszel chi-squared 
statistical value; and the significance of variables such as 
smoking, alcohol intake, physical exercises, gender, age, 
BMI (body mass index) and schooling were all consid-
ered. In the next stage we selected the variables that had 
significant values for the descriptive level. Non-conditional 
logistics analysis (since there was no pairing), was used 
in order to attain the odds ratio for hearing loss and to 
help investigate the existence of interactions between the 
variables, controlling the effects of the previously selected 
factors. The statistical modeling process was carried out 
using the Stepwise selection method.
The sample size was calculated using the Epi 6 
software, considering data from a pilot study developed 
with the population in question, in which the ratio of 
hearing loss and high blood pressure individuals was 
defined (37.7%) as was the ratio of individuals without 
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hearing loss and high blood pressure (18.8%), with age 
varying between 45 and 64 years. With an odds ratio of 
2.63 and a power of 95% the total N of participants was 
estimated to be 308.
RESULTS
As to the complete distribution of the cases and 
controls according to hypertension and hearing loss, we 
saw that 72 individuals had hearing loss and high blood 
pressure, 82 had hearing loss and no normal blood pres-
sure, 46 did not have hearing loss but had high blood 
pressure and 108 did not show hearing loss, nor high 
blood pressure. (Table 1).
The cases presented average age in years of 56.1, 
a little higher than the 52.8 presented by the control 
group.
There were more women among the cases 57.8%, 
and among the controls 77.3% when compared to men.
We could notice that, regarding schooling, all the 
groups presented higher incidence of individuals with first 
grade education completed, and among individuals with 
hearing loss and hypertension the incidence was 30.6%; 
among individuals with hearing loss and no high blood 
pressure, the incidence was 23.5%, among individuals with-
out hearing loss and high blood pressure the frequence 
was 50% and among individuals without hearing loss and 
without high blood pressure, the frequence was 26.9%.
Most individuals in this research did not smoke; 
among the individuals with hearing loss and high blood 
Table 1. Complete distribution of cases and controls according to high 
blood pressure and hearing loss.
Arterial Hypertension HEARING LOSS
Yes No
n % n %
YES 72 46,8 46  29,9
NO 82 53,2 108  70,1
TOTAL 154 100,0 154 100,0
OR=2,06[1,26< OR<3,39]; χ2 = 8,59 (p= 0,0034)
without arterial hypertension and without hearing loss, 
94.4% reported the same (p= 0.4206).
As to the practice of physical exercises, in the group 
of individuals with hearing loss and arterial hypertension, 
63.9% reported they did not practice any type of exercise; 
in the group of patients with hearing loss and without 
arterial hypertension, 65.9%; in the group without hear-
ing loss and with arterial hypertension, 67.4%; and in the 
group without arterial hypertension and without hearing 
loss, 68.5% reported the same (p=0.9298).
As to the type of hearing loss in the sample, the 
individuals with arterial hypertension and those without 
arterial hypertension presented a similar frequence of 
sensorineural hearing loss, and in the first group, 83.7% 
of the ears presented the aforementioned loss, while in 
the second group, 81.8% had it (p=0.1310).
As to the degree of hearing loss in the sample, the 
individuals with arterial hypertension and those without 
it had a similar frequence of mild hearing loss, in the first 
group this rate was of 62.0% and in the second group 
63.6% (p=0.0881).
The arithmetic average of body mass index in the 
group of individuals without hearing loss and with arterial 
hypertension was of 30.3 and in the group with hearing 
loss and arterial hypertension it was of 29.7; while the 
group with hearing loss and without arterial hypertension 
this value was of 27.6 and in the group without hearing 
loss and no hypertension this number was of 26.8, show-
ing that in this study there was a higher body mass index 
in the individuals with arterial hypertension.
As to the use of anti-hypertensive medication, we 
noticed that of the 72 cases with hypertension, only 5 
(6.9%) did not use the medication, and of the 46 controls 
who had hypertension, only one (2.1%) did not use medi-
cations; thus, of the 118 hypertensive individuals in this 
study, only 6 (5%) did not use medication to treat their 
hypertension at the time of the exam. 
As to the association of antihypertensive drugs, 24 
cases (33.3%) and 11 controls (23.9%) used more than one 
anti-hypertension drug, which prevailed among cases - 6 
individuals (8.3%) and among the controls - 5 individu-
als (10.8%), with association of diuretic agents plus ACE 
inhibitors.
Among the cases, 34 (47.2%), and among controls, 
17 (36.9%) used ACE inhibitors.
Among the cases, 25 individuals, and among con-
trols, 14 used diuretic agents, 17 of the cases and 15 of 
the controls used β-blockers and one of the cases and 3 
controls used angiotensin II antagonist inhibitors; 8 of the 
cases and 2 controls used calcium channel blockers; 3 of 
the cases and 1 control used α-blockers; and 4 cases and 
5 controls used other anti-hypertension medications such 
as cloridine, α - metildopa and minoxidil and, 7 cases and 
4 controls were using other drugs simultaneously such as 
pressure, 84.7% did not smoke. Among individuals with 
hearing loss and without high blood pressure, 91.3% did 
not smoke and among the group without hypertension and 
without hearing loss, 83.3% did not smoke (p= 0.5920).
Most individuals in this research did not drink al-
coholic beverages; the group of individuals with hearing 
loss and hypertension, 94.4% said they did not ingest al-
cohol; in the group with hearing loss and without arterial 
hypertension, 96.3%; in the group without hearing loss 
and with arterial hypertension, 100%; and in the group 
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antiarrhythmics, vessel dilators and antiplatelet aggrega-
tion drugs.
Arterial hypertension, advanced age and male 
gender proved to be independent risk factors for hearing 
loss (Table 2).
The logistic regression model shows that hyperten-
sion (p=0.0322), higher age (p=0.0011) and male gender 
(p=0.0004) are independent risk factors for hearing loss.
DISCUSSION
The present study showed the existence of an as-
sociation between hearing loss and arterial hypertension 
in individuals between 45 and 64 years, and contributed 
with such evidence to explain this controversial aspect 
of human health. Such association between hearing loss 
and arterial hypertension has been an important object 
of research in recent decades, with highly antagonic con-
clusions, and some authors back this association8,9, while 
others deny it and even present different results in studies 
carried out at distinct times8-11,16-20.
As to the methodological characteristics of this 
study, the care taken in outlining the age factor, focusing 
on the age range of middle aged individuals, between 45 
and 64 years as they do in hypertension investigations22-
23, the strict exclusion criteria, eliminating individuals 
with diseases and specific activities capable of producing 
hearing alterations and the care taken in diagnosing their 
hearing loss and arterial hypertension certainly helped to 
reduce selection biases. Notwithstanding, memory biases 
during history taking, use of ototoxic medication may have 
affected the results; notwithstanding, in studies about in-
formation reliability, for example regarding metabolic and 
vascular alterations24, or of information biases, for example 
regarding metabolic and vascular alterations biases yet 
undiagnosed or not reported by the patient. 
Pertaining to the statistical analysis, we used logistics 
regression since this is a model that with a good adjust-
ment obeys the principle of sobriety, and it also describes 
the relation between one result and a set of simultaneous 
explanatory variables, since the logistics analysis controls 
a great number of variables at the same time, allowing the 
data to be used in a more efficient way25. In this study we 
Table 2. Results of the logistics analysis for hearing loss with independent variables.
Risk factors Odds ratio I.C.I. 95% Coefficient Standard error Wald test P value
AH(Y/N) 1,7277 1,0475 2,8496 0,5468 0,2553 2,1419 0,0322
AGE(high/low) 2,2499 1,3822 3,6620 0,8109 0,2486 3,2622 0,0011
GENDER(Male/
Fem)
2,5444 1,5244 4,2470 0,9339 0,2614 3,5730 0,0004
Total * * * -0,1364 0,2189 -0,6230 0,5333
could see a certain uniformity among the results obtained 
with the application of the logistics regression analysis that 
became practically mandatory since it has a greater power 
for exploring the variables in question. 
With aging, there is a higher number of chronic dis-
eases. Systemic arterial hypertension and hearing loss have 
important prevalence in the elderly population20. In this 
paper we observed that although the sample individuals 
were between 45 and 64 years (middle aged), the higher 
age range (p=0.0011) proved to be an independent risk 
factor for hearing loss when we consider the logistic re-
gression model used. This is probably due to the fact that, 
as we all know, with age there are structural alterations in 
the whole body, including the hearing system1.
Despite these structural changes caused by age, 
many authors mention presbyacusia, which usually start at 
around 65 years of age and is a hearing loss type accruing 
from aging itself and is associated to specific audiologic 
characteristics, being a descending, bilateral and sym-
metrical sensorineural hearing loss type1-26,27.
Some studies justify that the sensorineural hearing 
loss that happens with aging is related to a microcircula-
tory insufficiency that occurs due to vascular occlusion 
caused by emboli, hemorrhage or vasospasm, and these 
happen because of a syndrome of hyperviscosity or mi-
croangiopathy caused by diabetes or hypertension, and 
the latter could, through histopathological mechanisms 
cause the sensorineural hearing loss28,29.
In an experimental study using rats with arterial hy-
pertension, it was noted that hypertension is an important 
risk factor for age-related hearing loss. Action potentials, 
electrochemistry and potassium concentration in the co-
chlea of these genetically predisposed to hypertension 
animals were measured together with their normotension 
counterparts.  With aging, the hypertensive animals had a 
higher action potential threshold, a higher electrochemical 
potential happened only in the extremely aged animals, 
while potassium concentration increased not only in the 
endolymphatic cells, but also in the perilymphatic ones. 
These data suggest that ionic modifications to the cell 
action potential are involved in the hearing reduction 
that happens to hypertensive animals. These data help us 
understand hearing loss in hypertensive individuals7.
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It is known, however, that environmental factors, 
to which human beings may be subject, such as noise, 
inhalation of toxic substances, certain metabolic and circu-
latory alterations; infections, injuries of many natures and 
genetic inheritance, may also influence the individual’s 
hearing, often times accelerating the process of cochlear 
degeneration1-11-30,31. In the present study, aiming at reduc-
ing selection bias problems, we excluded those individuals 
who worked in noisy environments, had diabetes, had 
previous history of hospital stay and ingestion of ototoxic 
drugs; notwithstanding, we know that in large urban 
centers there is intense exposure to environmental noise 
– depending on where the person lives, works, spends 
his leisure time, which may all provide excessive and 
long standing noise to the individual, thus accelerating 
hearing aging. 
As to gender, there was a difference in the men to 
women ratio in both groups, due to the fact that we did 
not pair the sample – cases were taken at random, during 
regular medical visits, while the controls were brought by 
the hearing impaired patients themselves, under the in-
struction that they could not be siblings or parents of these 
patients, and we had to take off the study a greater number 
of men because of a hearing impairment suspicion – those 
who worked or had worked in noisy environments. 
Many papers have approached the theme gender 
and hearing loss in relation to age32,33. Dubno et al.34, after 
a study that correlated age, gender and hearing acuity for 
the spoken Word, reported that males had a significant 
age-related drop in their hearing acuity and speech recog-
nition, while women did not show such pattern. Pearson 
et al.35 , after a longitudinal study involving 681 men and 
416 women, without signs of specific hearing disorders, 
unilateral or noise-induced hearing loss, reported that there 
is a two-fold increase in the speed at which men lose their 
hearing, when compared to women, showing that age and 
gender are indeed related to hearing loss even in groups 
without signs of noise-induced hearing loss. 
Collet et al.36, after studying the influence of age and 
gender in ABR, reported that, using logistics regression it 
was possible to determine a correlation with hearing loss. 
In the present study, carried out with male individuals with 
ages varying between 45 and 64 years, the male gender 
(p=0.0004) proved to be an independent risk factor for 
hearing loss through the model of logistics regression we 
used. This corroborates the studies that have reported a 
significant drop in hearing acuity for male individuals as 
they age20,34-36.
Due to a reduction in mortality rates, there is an 
increase in life expectancy all over the world. In Brazil, ac-
cording to the recent census (2000), the elderly population 
corresponded to 5.85% of the population, and its growth 
was of 1.02% in relation to the previousscensus from the 
90’s. The aging index also increased from 13.90% in 1991 
to 19.77% in 200020.
Since medical development together with socio-
economical factors have drastically reduced the number 
of premature deaths, cardiovascular diseases and cancer 
are actually the main causes of death; and this is due not 
only to an increase in the incidence of these pathologies, 
but also to a greater longevity and mainly to medication 
control and efficacy in eliminating infectious diseases37,38. 
The major factors that affect health today are the chronic 
diseases caused by genetics, life style, the environment 
and aging itself; thus, we should focus our attention on 
the last years of life of our patients aiming at increasing 
the number of health elderly, capable of maintaining their 
physical and mental functions until close to death16,37-40.
The new challenge are the chronic conditions re-
lated to aging, many detectable and preventable already 
in middle age, and such conditions are currently seen in 
the many health care specialties in delaying those. Fries 
sees this as “morbidity compression”, in other words, live 
a life with relative health and compress diseases to a short 
period of time right before death41. In order to achieve 
it, it is necessary to adopt principles and strategies for 
preventive care and health maintenance that should be 
particularly geared to each patient individually, aiming at 
improving their life quality. Among such preventive care, 
we should take care of the onset, as the many problems 
accruing from arterial hypertension, among which we 
mention hearing loss.
According to the Brazilian Council on Arterial Hy-
pertension, high blood pressure is multicausal and multi-
factorial, because most of the time it does not cause any 
symptoms to the patients and it involves education aiming 
at achieving a number of goals, and for that there is the 
need to form a multidisciplinary care team18. The consensus 
also states that the multidisciplinary team can and should 
have processionals that are, in one way or the other,  deal-
ing with hypertensive patients. Physicians, nurses, nurse 
technicians, nutritionists, psychologists, social workers, 
community agents, physical education teachers, pharma-
ceutics and, administrative personnel should all be part 
of the team; and at no time they mention the speech and 
hearing therapist, who, according to article 442 have the 
competence to participate in diagnostic teams, carrying 
out the oral, voice, written and hearing assessment and 
collaborate in speech and hearing topics related to other 
sciences. Since arterial hypertension has proven to be a risk 
factor for hearing loss, and such onset should be checked 
in this population, the speech and hearing therapist, as 
the one responsible for hearing assessment, should be 
included as an effective member of such multiprofessional 
team involved with arterial hypertension. 
The care related to arterial hypertension and hearing 
will certainly serve to avoid the frustrations caused by the 
reduction in one’s capacity to understand oral language 
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caused by a reduction in hearing accuity39,43,44,46, which may 
happen to arterial hypertensive individuals.
CONCLUSION
Since the study has shown that arterial hyperten-
sion is an independent risk factor for hearing loss, besides 
the male gender and advanced age, we highlight the 
importance of preventive processes that may mitigate the 
mechanisms that cause degeneration of the hearing ap-
paratus caused by circulatory problems, most specifically 
high blood pressure. 
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